Tag:
Pipex
Latest Headlines
Latest Headlines
Pipex acquires mid-stage RA program
Pipex Pharmaceuticals has acquired oral dnaJP1, a once-daily candidate for the treatment of rheumatoid arthritis which has completed a 160 patient Phase II clinical trial for the treatment of
